Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C

Summary

The purpose of this study is to evaluate the effect of PEGASYS® (peginterferon alfa-2a 40KD) plus Robatrol® (ribavirin) combination therapy given for 36 weeks versus 48 weeks on the clearance of HCV viremia 24 weeks after treatment end

Timeline

Start

2012-07

Primary completion

2014-07

Completion

2014-07

Outcome

Outcome not reported

Stopped: “early termination due to difficult collection of patients”

Drugs

Indications